Kaynes Technology Stock Price Valuation Analysis June 2026
India Ltd
Kaynes Technology India Limited, incorporated in 2008 and headquartered in Mysuru, Karnataka, is India’s most vertically integrated Electronics System Design and Manufacturing (ESDM) enterprise. With over three decades of institutional knowledge and 22 advanced manufacturing and design facilities — spanning Mysuru, Manesar, Pune, Chennai, Hyderabad, and Sanand — Kaynes offers conceptual design, process engineering, integrated manufacturing, and life-cycle support across the full electronics value chain.
The company listed on Indian exchanges in November 2022 via a ₹858 crore IPO (₹530 Cr fresh + ₹328 Cr OFS). Since listing, it has grown revenue at a 5-year CAGR exceeding 50%, making it among the fastest-growing industrial companies in India’s modern market history. Its competitive moat lies in its design-led approach — an ODM model enabling higher value-add and structurally superior margins versus pure-play assembly EMS players.
Served Verticals (FY26 mix): Automotive ~29%, Industrial ~26%, Aerospace & Defence ~15%, Railways ~10%, Medical ~8%, IoT/IT ~7%, Space & Nuclear ~5%. This sectoral diversification provides natural resilience against single-industry cyclicality — a structural advantage rarely replicated in the EMS peer universe.
Client Base: 500+ customers across 30+ countries, including marquee global MNCs in automotive, aerospace, and defence. Decades-long Tier-1 OEM relationships create sticky, recurring revenue streams.
Technology Platforms: SMT, THT, Box-Build Assembly, ODM in smart IoT/GaN power electronics, MEMS-based OSAT packaging, AR/VR hardware, and Brushless Drive Technology. The Qualcomm JV for design tools adds ecosystem depth.
New Growth Engines (FY25–26): OSAT facility at Sanand, Gujarat — India’s first commercial multi-chip module delivered in partnership with Alpha & Omega Semiconductor and Mitsui. HDI PCB manufacturing in Chennai nearing operational readiness, targeting telecom, defence, and medical applications.
Kaynes is executing a rare and ambitious transformation — from service-led EMS to product-led ESDM with operational OSAT and upcoming HDI PCB capabilities. This transition significantly expands the company’s addressable TAM, lifts its sustainable margin ceiling, and repositions it from a contract manufacturer to a technology-enabler in India’s semiconductor and electronics ecosystem.
Kaynes has compounded revenue at ~57% CAGR over FY22–FY25, making it one of India’s fastest-growing industrial companies by any measure. FY26 showed a moderation to 33% growth — still exceptional in absolute terms — reflecting both a deliberate shift toward higher-value product categories and tangible execution challenges in H2 FY26, particularly in the railway/Kavach segment and smart metering.
| Particulars (₹ Cr) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue from Operations | 706 | 1,126 | 1,805 | 2,722 | 3,626 |
| YoY Revenue Growth | — | 59.5% | 60.3% | 50.8% | 33.2% |
| EBITDA | 94 | 168 | 254 | 411 | 574 |
| EBITDA Margin | 13.3% | 14.9% | 14.1% | 15.1% | 15.8% |
| Depreciation & Amortisation | 13 | 19 | 25 | 45 | 75 |
| Finance Cost | 26 | 35 | 53 | 101 | 130 |
| Profit Before Tax | 59 | 126 | 232 | 372 | 418 |
| PAT (Consolidated) | 42 | 95 | 183 | 294 | 364 |
| PAT Margin | 5.9% | 8.5% | 10.2% | 10.8% | 10.0% |
| EPS (₹, Basic) | 7.0 | 15.6 | 27.7 | 44.2 | 54.9 |
| Revenue CAGR (FY22–FY26) | 50.3% | ||||
FY26 specifics: Revenue ₹3,626 Cr (+33% YoY); EBITDA ₹574 Cr (+40% YoY, 70 bps margin expansion); PAT ₹364 Cr (+24% YoY). Q4 FY26 disappointed — PAT fell 21.5% YoY to ₹91 Cr as interest cost and depreciation from new OSAT/PCB capex eroded profitability. Negative operating cash flow of ~₹460 Cr in FY26 due to extended working capital cycle (net WC days: 125 vs guidance of 85) remains the primary near-term concern and the key reason for the 47% stock correction from peak.
| Key Ratios | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE (%) | 27.1% | 16.7% | 11.0% | 11.0% | ~10.5% |
| ROCE (%) | 26.0% | 22.0% | 15.0% | 15.0% | ~14.5% |
| P/E at CMP (×) | — | — | — | 77.9× | 62.7× |
| P/B at CMP (×) | — | — | — | — | ~4.7× |
| EBITDA Margin | 13.3% | 14.9% | 14.1% | 15.1% | 15.8% |
Given Kaynes’ high-growth, capex-intensive profile, the DCF requires careful treatment of free cash flows. In the near term (FY27–FY28), substantial capex (~₹1,600–2,200 Cr/yr) and elevated working capital suppress FCF materially. Meaningful positive FCF normalises from FY29 onward as OSAT/PCB utilisation ramps and working capital discipline improves. The terminal value (~FY37+) dominates the valuation — sensitivity to WACC and terminal growth rate is high.
| Period | Revenue (₹ Cr) | EBITDA (₹ Cr) | Capex (₹ Cr) | Est. FCF (₹ Cr) | PV of FCF (₹ Cr) |
|---|---|---|---|---|---|
| FY27E | 5,200 | 858 | 2,200 | (780) | (697) |
| FY28E | 7,500 | 1,275 | 1,600 | (140) | (112) |
| FY29E | 9,200 | 1,656 | 800 | 430 | 307 |
| FY30E | 11,000 | 2,035 | 650 | 880 | 562 |
| FY31–36E (cumul.) | Compounding | ~18% margin | ~5% rev | ~₹4,800 | ~₹2,140 |
| Terminal Value (FY37+) | TGR 5%, WACC 12% | ~₹28,000 | |||
| DCF Intrinsic Value Per Share | ₹4,100–4,600 | ||||
Indian EMS stocks command significant growth premiums owing to secular ESDM tailwinds, PLI policy support, and multi-decade structural demand. Following the 47% correction from the October 2025 peak (₹7,705 → ₹3,444), Kaynes now trades at 63× TTM P/E — a more reasonable entry relative to its prior stratospheric 120×+ band.
| Company | CMP (₹) | Mkt Cap (Cr) | Rev FY26 (Cr) | EBITDA Margin | P/E TTM | EV/EBITDA | Rev CAGR FY26–28E | Broker View |
|---|---|---|---|---|---|---|---|---|
| Kaynes Technology | 3,444 | 22,900 | 3,626 | 15.8% | 62.9× | 38× | ~43% | Accumulate |
| Dixon Technologies | ~11,200 | ~67,000 | ~18,000 | ~4.5% | 70× | 42× | ~25% | Mixed |
| Syrma SGS Technology | ~700 | ~7,500 | ~4,200 | ~7.5% | 52× | 28× | ~35% | Top Pick |
| Amber Enterprises | ~6,800 | ~23,000 | ~12,000 | ~6.8% | 90× | 48× | ~28% | Overweight |
| Cyient DLM | ~480 | ~3,600 | ~1,600 | ~12.0% | 58× | 32× | ~30% | Overweight |
| Avalon Technologies | ~780 | ~2,400 | ~1,000 | ~13.0% | 65× | 35× | ~25% | Neutral |
Key insight: Kaynes commands a justified premium to consumer EMS assemblers (Dixon, Amber) on account of its structurally superior EBITDA margins (~15.8% vs 4–7% for high-volume consumer peers), design-led positioning, and unique OSAT/PCB optionality. However, relative to Syrma SGS — which delivered cleaner execution and better earnings quality in FY26 — Kaynes’ premium appears partially at risk until cash flow discipline and OSAT utilisation become visible in quarterly numbers. On FY27E EPS of ₹82–85, the stock trades at ~41–43× — a materially more compelling entry point.
Kaynes is in a peak capex deployment phase. The asset-based method provides a conservative floor valuation anchored to deployed capital, and is instructive in understanding just how much “growth premium” the market is pricing at any given CMP.
| Asset Component | Book Value (₹ Cr, FY26E) | Notes |
|---|---|---|
| Net Fixed Assets (tangible) | ~1,400–1,600 | OSAT facility, Manesar, Pune, Chennai PCB setup |
| Net Working Capital | ~1,500–1,800 | Elevated; 125 NWC days — key monitorable |
| Investments & Cash | ~400–600 | Post-capex deployment of QIP proceeds |
| Total Assets Deployed | ~3,300–4,000 | — |
| Total Borrowings (incl. bill disc.) | ~1,200–1,500 | Effective cost ~10% |
| Net Asset Value (Equity) | ~1,800–2,500 | ~₹272–377/share (66 Mn shares) |
| P/B at CMP ₹3,444 | ~4.7× Book Value | Premium justified by ESDM growth; NAV not primary value driver |
The gap between NAV (~₹325/share) and CMP (₹3,444) is the “growth premium” being assigned by the market — roughly 10.5× the asset base. For a company guiding toward $2 billion in revenue by FY30 with an operational OSAT facility and PCB manufacturing, this premium is reasonable but must be earned through sustained execution.
EPV captures the value of Kaynes’ current normalised earning power — ignoring all future growth — capitalised at the cost of capital. This conservative methodology isolates the earnings capacity of existing assets, quantifying what portion of the current market cap is attributable to growth expectations versus current business productivity.
| EPV Component | Value (₹ Cr) | Basis |
|---|---|---|
| Normalised EBIT (FY26, adj.) | ~320–360 | EBITDA ₹574 Cr less D&A ₹75 Cr, less interest ₹130 Cr |
| Normalised NOPAT (25% tax) | ~240–270 | Post-tax operating earnings |
| Cost of Capital (WACC) | 12.0% | Standard assumption |
| EPV of Operations | ~2,000–2,250 | NOPAT ÷ WACC |
| Add: Cash & Investments | ~500 | Liquid buffer |
| Less: Total Debt | ~(1,300) | Including bill discounting |
| Equity EPV | ~1,200–1,450 | — |
| EPV Per Share | ~₹181–219 | At 66 Mn diluted shares |
The EPV of ~₹200/share vs CMP of ₹3,444 means the market is assigning ~₹3,244/share of growth value — the premium Kaynes must earn through OSAT scale-up, PCB profitability, and sustained 40%+ revenue CAGR. The EPV gap is expected for a high-growth ESDM company; the key question is whether the growth milestones are achievable within the implied timeframe.
Kaynes now operates four distinct business engines — core EMS, OSAT, HDI PCB, and smart metering — each with different growth profiles, margin structures, and relevant comparables. SOTP is analytically the most appropriate methodology to assign fair value and is the anchor of our target price.
| Business Segment | FY27E Revenue (₹ Cr) | EBITDA Margin | EBITDA (₹ Cr) | EV/EBITDA | Segment EV (₹ Cr) |
|---|---|---|---|---|---|
| Core EMS (Auto / Industrial / Aero / Medical) | 4,200 | 14.5% | 609 | 35× | 21,315 |
| OSAT (Sanand Semiconductor Facility) | 500 | 8–10% (ramp) | 45 | 40× | 1,800 |
| HDI PCB Manufacturing (Chennai) | 300 | 12–14% (ramp) | 39 | 38× | 1,482 |
| Smart Metering (Iskraemeco India) | 200 | 10% | 20 | 30× | 600 |
| Total Enterprise Value | 25,197 | ||||
| Bridge to Equity Value | ₹ Crore |
|---|---|
| Total Enterprise Value | 25,197 |
| Less: Net Debt (incl. bill discounting) | (1,300) |
| Add: Cash & Liquid Investments | 500 |
| Equity Value | 24,397 |
| SOTP Per Share (66 Mn shares) | ₹3,697 |
SOTP yields a base-case fair value of ~₹3,700 for FY27E, rising toward ₹4,500–5,200 if OSAT and PCB ramp as per management’s roadmap. The current CMP of ₹3,444 implies the market is pricing Kaynes at a modest discount to SOTP — providing a reasonable risk-adjusted accumulation opportunity.
Synthesising DCF (₹4,100–4,600), SOTP (₹3,700–4,500), and peer multiples (₹3,700–4,200 at 45–52× FY27E EPS of ₹82–85), we derive a structured buy range for medium-term investors with an 18–24 month horizon. The 47% correction has compressed valuations to a compelling entry window not seen since the early post-IPO period.
At CMP ₹3,444, Kaynes sits in the Accumulate zone. Given execution uncertainties (working capital, OSAT ramp), we recommend a staged approach — 40% of desired position now, 30% at ₹3,100–3,200, and the final 30% upon Q1 FY27 results confirming improving OCF and OSAT utilisation metrics.
Probability-weighted target = (0.25 × ₹2,600) + (0.55 × ₹4,200) + (0.20 × ₹5,500) = ₹4,015. This risk-adjusted upside of ~17% from CMP justifies the Accumulate recommendation with a staged entry framework.
Kaynes deserves a full exit or significant trim when the stock re-rates to valuations that price in execution perfection — particularly at elevated multiples where any slippage in OSAT ramp, margin delivery, or cash flow improvement triggers sharp de-rating risk.
The ongoing scrutiny around Iskraemeco-related inter-company disclosure mismatches flagged by a brokerage in FY25 filings warrants close monitoring. Mismatches in related-party transaction disclosures (₹320 Cr payables, ₹190 Cr receivables not reflected in parent disclosures) must be resolved transparently in FY26 audited accounts to preserve investment-grade credibility.
1. OSAT — Pioneering India’s Semiconductor Packaging Industry: The Sanand OSAT facility delivered India’s first commercial multi-chip module within 14 months of groundbreaking — a remarkable industrial achievement. Partnerships with Alpha & Omega Semiconductor, Mitsui, Infineon, and L&T Semiconductor anchor near-term order flow. As India’s PLI scheme for semiconductor packaging matures, Kaynes is uniquely positioned as the only EMS company with operational OSAT capability in India. OSAT EBITDA margins normalise at 12–15% at full utilisation (vs 8% in ramp phase), representing ~200 bps margin uplift at scale.
2. HDI PCB Manufacturing — ₹12,800 Cr Import Substitution Opportunity: India imports ~₹12,800 Cr of bare PCBs annually, predominantly from China (43%), Hong Kong (28%), and Taiwan (10%). Kaynes’ Chennai HDI PCB facility, once fully operational, targets high-value defence, aerospace, telecom, and medical applications. The ECMS (Electronics Components Manufacturing Scheme) provides additional capex subsidy support. PCB manufacturing commands 17–20% EBITDA margins at full utilisation — the most margin-accretive segment in the portfolio.
3. Revenue Guidance of $1 Bn by FY28: Management has guided for $1 Bn (~₹8,300 Cr) revenue by FY28 and $2 Bn by FY30. Our more conservative base case of ₹7,500 Cr for FY28 implies ~43% CAGR from FY26 — achievable if OSAT and PCB ramp on schedule. The $2 billion vision by FY30 represents a 4-year revenue compounding of ~40% from FY26 — aggressive but not implausible given the current order book coverage.
4. Export Ramp — Unlocking 5× Larger Addressable Market: Export revenue was ~9% of FY24 revenue. Management targets 20%+ exports by FY27, aided by Digicom Electronics (USA subsidiary), ITAR certification, and growing traction with international aerospace/defence clients. Export mix improvement de-risks currency exposure and opens addressable markets significantly larger than the domestic Indian EMS market.
5. Government Policy Tailwinds — Decade-Long Structural Runway: PLI for electronics, ECMS for components/PCBs, Defence Acquisition Policy indigenisation mandates, and Smart Cities infrastructure collectively create a multi-decade runway for deep-tech ESDM players. Kaynes’ aerospace/defence certifications and decades-long Tier-1 relationships make it a natural and favoured beneficiary of Make-in-India electronics policy architecture.
- OSAT facility reaches 30%+ utilisation by Q2 FY27; PAT contribution turns positive ahead of schedule
- HDI PCB secures first defence/aerospace contract; front-loaded margin accretion begins
- Working capital days improve structurally to below 90 by Q2 FY27 — OCF turns positive
- Export revenue exceeds 15% of FY27 revenue; USD-denominated contracts provide margin insulation
- Kavach (railway safety) programme accelerates; deferred Kaynes railway orders flow into Q1–Q2 FY27
- Strategic investor or global PE fund block deal validates enterprise value at premium
- Two consecutive quarters of positive OCF — key institutional re-rating trigger
- NWC days rising above 140 signals structural inefficiency; receivable quality a key watch item
- Negative OCF persisting through FY27 forces dilutive QIP; equity overhang risk
- Iskraemeco disclosure mismatches escalate to auditor qualification or SEBI inquiry
- OSAT ramp delayed 18+ months due to technology transfer or subsidy disbursement delays
- China-Taiwan geopolitical shock spikes component costs; gross margins compress 150–200 bps
- High-beta stock (β=1.38) amplifies broad market drawdowns; sector-wide de-rating possible
- Execution gaps in railway/Kavach segment persist beyond Q2 FY27
Quarterly monitoring checklist: Net Working Capital Days (target: below 95 by FY27 Q2) · Operating Cash Flow trajectory · OSAT utilisation rate · PCB facility commissioning date · Order book conversion ratio · Promoter pledging level · Iskraemeco disclosure resolution
This analysis suggests that Kaynes Technology India Limited represents a compelling accumulate opportunity at current levels, following its 47% correction from the October 2025 peak of ₹7,705. The near-term picture carries real stress — Q4 FY26 delivered a 21.5% PAT decline, negative operating cash flow of ~₹460 crore, and net working capital days stuck at 125 against guidance of 85. These are legitimate fundamental disappointments, not temporary noise, and the market has priced them in harshly. Yet the structural investment narrative remains fully intact — and in several respects, has been strengthened.
Kaynes is executing a genuinely rare industrial transition: from a high-quality contract electronics manufacturer to India’s first vertically integrated ESDM player with operational OSAT, upcoming HDI PCB manufacturing, design-led ODM capabilities across GaN and MEMS, and a decade-long order book anchored by automotive, aerospace, and defence clients who do not switch suppliers easily. The commissioning of India’s first commercial multi-chip module from the Sanand OSAT facility within 14 months of groundbreaking is a landmark milestone that most EMS competitors will not replicate for 3–5 years. The order book of ₹8,366 crore (~2.3× FY26 revenue), confirmed demand from 500+ customers across 30+ countries, and management’s $1 billion FY28 revenue guidance provide a credible medium-term foundation.
Our probability-weighted target price of ₹4,200 (blending SOTP ₹3,697, DCF ₹4,100–4,600, and forward P/E at 51× FY27E EPS) offers approximately 22% upside from CMP in the base case. This analysis recommends accumulating in tranches — building 40% of the desired position at current levels (₹3,300–3,500), adding 30% below ₹3,100 if macro-driven weakness provides the opportunity, and the final tranche after confirmation of improving cash conversion and OSAT utilisation milestones in Q1 FY27 results. Investors with a 24-month view, comfort with near-term earnings volatility, and conviction in India’s electronics manufacturing decade will find this one of the more rewarding entry points into the ESDM theme.
Disclaimer: This research report is published by Zumedha Equity Research for informational and educational purposes only. It does not constitute investment advice, a solicitation to buy or sell securities, or a recommendation to any specific investor. All financial data and figures are sourced from publicly available company filings, NSE/BSE exchange disclosures, and third-party research aggregators as of May 2026. Past performance is not indicative of future results. Investors should conduct independent due diligence and consult a SEBI-registered investment advisor before making any investment decision. Zumedha Equity Research does not hold any position in Kaynes Technology India Ltd at the time of publication. Equity investments are subject to market, liquidity, regulatory, and business risks. Please read all related documents carefully before investing. This report is for educational purposes only and does not constitute financial advice under SEBI (Investment Advisers) Regulations, 2013.
